e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Biomarkers in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is YKL-40 a prognostic marker in sarcoidosis?
C. B. Svendsen, N. Milman, J. S. Johansen (Copenhagen, Denmark)
Source:
Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Session:
Biomarkers in diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
5669
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. B. Svendsen, N. Milman, J. S. Johansen (Copenhagen, Denmark). Is YKL-40 a prognostic marker in sarcoidosis?. Eur Respir J 2010; 36: Suppl. 54, 5669
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Serum CC16 is a potential predictor for IPF diagnosis and prognosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017
Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Pro-adrenomedullin as prognostic marker in patients with CAP
Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers
Year: 2008
Induced sputum TNF-α level as possible prognostic factor in sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 115s
Year: 2007
YKL-40 protein as a marker of asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Circulating total leptin as a diagnostic and prognostic biomarker in sepsis
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
The serum YKL-40 is a useful biomarker for asthma
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker?
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Serum KL-6 as a marker of disease progression in SSc-ILD
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Circulating fibrocytes and collagen turnover products in UIP: marker of disease activity and prognostic tool?
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007
alpha-v-beta-6 integrin may be a potential prognostic biomarker in interstitial lung disease
Source: Eur Respir J 2015; 46: 486-494
Year: 2015
Blood leukocyte levels as potential prognostic markers in IPF
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Prognostic predictors of course sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003
Serum biomarkers in SSc-ILD: association with presence, severity and prognosis
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Relevant prognostic predictors of sarcoidosis course
Source: Eur Respir J 2001; 18: Suppl. 33, 345s
Year: 2001
Clinical utility of CCL15 as a prognostic biomarker for hypersensitivity pneumonitis
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Year: 2019
Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020
Year: 2020
Elevation of circulating endothelial cell levels in lung cancer – a new prognostic and/or predictive marker?
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept